Efficacy of Mabthera (anti CD20 Ab) in patients with relapsed/progressed Hairy cell leukemia.

被引：0
|
作者：
Lauria, F
Lenoci, M
Annino, L
Raspadori, D
Marotta, G
Bocchia, M
Gentili, S
La Manda, M
Marconcini, S
Zinzani, PL
机构：
[1] Univ Siena, I-53100 Siena, Italy
[2] Univ La Sapienza, Rome, Italy
[3] Seragnoli, Bologna, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
592
引用
收藏
页码：138A / 138A
页数：1
相关论文
共 50 条
  • [21] Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab
    Angelopoulou, Maria K.
    Pangalis, Gerassimos A.
    Sachanas, Sotirios
    Kokoris, Styliani I.
    Anargyrou, Konstantinos
    Galani, Zaharoula
    Kalpadakis, Christina
    Vassilakopoulos, Theodoros P.
    LEUKEMIA & LYMPHOMA, 2008, 49 (09) : 1817 - 1820
  • [22] GM-CSF treatment does not up-regulate expression of CD20 in vivo in patients with chronic lymphocytic leukemia.
    Pearson, MD
    Buj, V
    Shinn, C
    Waymer, SF
    Sickler, J
    Flynn, JM
    Lucas, MS
    Flinn, IW
    Byrd, JC
    BLOOD, 2000, 96 (11) : 166A - 167A
  • [23] Efficacy and safety of an anti-FLT3 antibody (LY3012218) in patients with relapsed acute myeloid leukemia.
    Sanford, David
    Blum, William G.
    Ravandi, Farhad
    Klisovic, Rebecca B.
    Borthakur, Gautam
    Walker, Alison R.
    Garcia-Manero, Guillermo
    Marcucci, Guido
    Wierda, William G.
    Whitman, Susan P.
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] THE ADDITION OF CD20 MONOCLONAL ANTIBODY TO LENALIDOMIDE IMPROVES RESPONSE RATE AND SURVIVAL IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Thompson, P. A.
    Keating, M. J.
    Wierda, W. G.
    Falchi, L.
    O'Brien, S. M.
    Ferrajoli, A.
    HAEMATOLOGICA, 2014, 99 : 250 - 251
  • [25] Antibody against CD20 in patients with B cell malignancy
    Adamson, PJ
    Zola, H
    Nicholson, IC
    Pilkington, G
    Hohmann, A
    LEUKEMIA RESEARCH, 2001, 25 (12) : 1047 - 1050
  • [26] CD3/CD20 lymphocytes could be implicated in supporting hematological remission after chemotherapy in acute myeloid leukemia.
    Stagno, F
    Guglielmo, P
    Consoli, U
    Fiumara, P
    Anastasi, ML
    Parisi, G
    Giustolisi, R
    BLOOD, 1997, 90 (10) : 2975 - 2975
  • [27] MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB
    Rice, Ceara
    Ghandi-Das, Dhivya
    Negi, Anurag
    RHEUMATOLOGY, 2020, 59 : 94 - 94
  • [28] CELL SURFACE CD20 ANTIGEN EXPRESSION ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Giordano, A.
    Curci, P.
    Rizzi, R.
    Perrone, T.
    Delia, M.
    Mestice, A.
    Nardelli, G.
    Di Tardo, I.
    Specchia, G.
    HAEMATOLOGICA, 2013, 98 : 541 - 541
  • [29] INFLUENCE OF HISTONE DEACETYLASE INHIBITORS (HDACI) ON CD20 EXPRESSION AND EFFICACY OF ANTI-CD20 MONOCLONAL ANTIBODIES
    Wanczyk, M.
    Kozikowski, M.
    Dwojak, M.
    Bojarczuk, K.
    Winiarska, M.
    HAEMATOLOGICA, 2013, 98 : 409 - 409
  • [30] Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?
    Troussard, Xavier
    Maitre, Elsa
    Paillassa, Warne
    BULLETIN DU CANCER, 2021, 108 (7-8) : 771 - 778
12345